Clinical trial
Developing Neuronal KCNQ Channel Modulators for Mood Disorders
NCT03043560 is registered in ClinicalTrials.gov with James Murrough as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Developing Neuronal KCNQ Channel Modulators for Mood Disorders
- Lead sponsor
- James Murrough
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 25, 2017
- Completion date
- August 30, 2019
- Enrollment
- 45 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.